Skip to main content
. 2020 Mar 19;11:371. doi: 10.3389/fimmu.2020.00371

Table 3.

Lymphocytes subsets evaluated by SCID-RTE tube.

Patient code Disease Category CD3+ of Lym CD3+ abs TCRgd+ of T TCRgd+ abs CD4+ T of T CD4+T abs CD8+ T of T CD8+T abs CD4+RTE of CD4 CD4+RTE abs Naive CD4+ of CD4 Naive CD4+ abs Naive CD8+ of CD8 Naive CD8+ abs HLA-DR+ of CD4 HLA-DR+ CD4+ abs HLA-DR+ of CD8 HLA-DR+ CD8+ abs
Case_1 CD3E SCID 7 246 0 0 5 13 93 228 0 0 0 0 2 5 93 12 83 188
Case_2 ADA SCID 55 18 13 2 1 0 83 15 0 0 0 0 0 0 n/a n/a 93 14
Case_3 JAK3 SCID 69 5,610 1 67 4 210 94 5,256 0 0 0 1 2 117 64 134 95 4,967
Case_4 JAK3 SCID 2 15 3 0 1 0 85 12 0 0 0 0 0 0 n/a n/a 99 12
Case_5 JAK3 SCID 80 2,247 0 4 98 2,202 1 23 0 0 0 1 0 0 86 1,896 86 19
Case_6 XLF SCID 38 294 89 263 0 1 2 7 0 0 0 0 0 0 n/a n/a 64 5
Case_7 Artemis SCID 18 84 55 46 38 31 1 1 6 2 6 2 31 0 88 28 44 0
Case_8 RAG2 SCID 2 40 1 1 71 29 1 0 0 0 0 0 17 0 91 26 n/a n/a
Case_9 RAG2 SCID 32 78 5 4 86 67 5 4 0 0 0 0 3 0 66 44 77 3
Case_10 RAG1 SCID 68 4,621 3 158 43 1,964 44 2,024 0 0 0 0 0 1 85 1,661 86 1,739
Case_11 RAG1 SCID 69 1,916 6 109 88 1,690 3 64 0 0 0 2 1 1 68 1,154 83 53
Case_12 IL2RG SCID 12 92 0 0 71 65 28 25 0 0 0 0 4 1 94 61 81 20
Case_13 IL2RG SCID 0 1 5 0 31 0 1 0 0 0 0 0 0 0 n/a n/a n/a n/a
Case_14 IL2RG SCID 45 677 25 171 48 325 23 156 0 0 1 3 7 11 87 282 94 147
Case_15 IL2RG SCID 0 1 17 0 58 0 0 0 0 0 0 0 0 0 n/a n/a n/a n/a
Case_16 PNP other PID 63 281 3 7 48 134 37 105 0 0 0 0 0 0 63 84 99 103
Case_17 ZAP70 other PID 51 1,661 3 47 89 1,482 2 29 24 357 34 505 19 5 17 246 30 9
Case_18 WAS other PID 50 1,092 4 41 82 891 13 138 53 470 82 730 56 78 3 23 3 4
Case_19 WAS other PID 57 978 28 271 31 303 38 376 18 55 40 122 6 23 39 119 85 319
Case_20 del22q11.2 other PID 50 328 37 122 15 47 3 9 0 0 0 0 1 0 43 21 65 6
Case_21 del22q11.2 other PID 0 1 10 0 0 0 70 1 0 0 0 0 14 0 n/a n/a 58 1
Case_22 del22q11.2 other PID 27 1,592 9 138 65 1,030 22 344 56 579 71 729 87 300 5 56 4 14
Case_23 del22q11.2 other PID 33 756 8 63 65 493 22 169 50 246 72 356 87 147 4 20 4 7
Case_24 CDC42 other PID 63 465 39 180 34 159 23 107 40 63 66 105 58 63 6 10 21 22
Case_25 FOXP3 other PID 61 1,664 1 22 70 1,157 22 363 40 465 66 765 81 295 4 48 5 19
Case_26 FAS other PID 86 12,833 3 444 26 3,324 15 1,912 58 1,938 81 2,692 92 1,761 11 356 5 88
Controls
5th percentile 52 2,010 0.7 20 54 1,201 13 335 58 840 72 1,030 60 287 0 9 0 2
95th percentile 86 6,626 7 340 82 4,094 35 2,204 86 2,393 96 3,149 96 1,614 3 66 11 80
Sensitivity other PID 55% 91% 55% 20% 55% 82% 27% 64% 91% 91% 73% 91% 64% 73% 90% 40% 55% 27%
Sensitivity SCID 67% 80% 33% 60% 60% 80% 53% 87% 100% 100% 100% 100% 100% 100% 100% 50% 100% 33%

Absolute counts (abs) as 10e3/μl. Values outside the normal range are in bold. Range obtained in controls (5th and 95th percentile) is given below the table. Sensitivity to disclose abnormal values in other PID and SCID group is given for each measurement in the bottom two rows. Most informative parameters are highlighted in gray.